Dr. Darush Rahmani, D.O.
What this data tells you about Dr. Rahmani
Dr. Darush Rahmani is a rheumatology in Round Rock, TX, with 19 years in practice. Based on federal Medicare data, Dr. Rahmani performed 113,368 Medicare services across 2,838 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rahmani received a total of $1,020 from 11 pharmaceutical and/or device companies across 67 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rahmani is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 58,632 | $5 | $9 |
| Golimumab infusion (Simponi Aria) | 26,600 | $11 | $49 |
| Abatacept infusion (Orencia) | 13,450 | $34 | $85 |
| Infliximab infusion (Remicade) | 5,244 | $26 | $144 |
| Denosumab injection (Prolia/Xgeva) | 2,281 | $18 | $33 |
| Office visit, established patient (30-39 min) | 931 | $88 | $238 |
| Comprehensive metabolic blood panel | 888 | $10 | $47 |
| Complete blood count (CBC) with differential | 879 | $8 | $35 |
| Sed rate test (inflammation marker) | 833 | $3 | $8 |
| C-reactive protein test (inflammation marker) | 795 | $5 | $24 |
| Administration of chemotherapy into vein, 1 hour or less | 576 | $95 | $310 |
| Steroid injection (triamcinolone) | 512 | $1 | $6 |
| Injection, zoledronic acid, 1 mg | 130 | $6 | $73 |
| Chest X-ray, 2 views | 125 | $23 | $62 |
| Administration of chemotherapy into vein, each additional hour | 123 | $21 | $65 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 120 | $76 | $230 |
| Tuberculosis test, gamma interferon | 111 | $60 | $174 |
| New patient office visit (45-59 min) | 107 | $119 | $295 |
| X-ray of hand, minimum of 3 views | 103 | $24 | $74 |
| Vitamin D level test | 102 | $29 | $76 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 100 | $54 | $165 |
| Foot X-ray, 3+ views | 85 | $24 | $71 |
| Thyroid stimulating hormone (TSH) test | 84 | $16 | $75 |
| Knee X-ray, 3 views | 65 | $25 | $73 |
| Urinalysis with microscopic exam | 60 | $3 | $15 |
| Basic metabolic blood panel | 44 | $8 | $47 |
| Acute hepatitis panel | 44 | $47 | $135 |
| Uric acid level test | 39 | $4 | $21 |
| Drug injection, under skin or into muscle | 39 | $10 | $46 |
| Shoulder X-ray, 2+ views | 38 | $20 | $86 |
| Automated urinalysis | 38 | $2 | $15 |
| Creatine kinase (cardiac enzyme) level, total | 31 | $6 | $30 |
| Flu vaccine administration | 30 | $30 | $39 |
| Urine culture, bacterial colony count | 28 | $8 | $37 |
| Flu vaccine, high-dose | 28 | $72 | $74 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 23 | $47 | $145 |
| Lipid panel (cholesterol and triglycerides) | 21 | $13 | $60 |
| X-ray of lower and sacral spine, minimum of 4 views | 16 | $37 | $120 |
| X-ray of both hips, 3-4 views | 13 | $40 | $97 |
Industry Payment Transparency
Open Payments through 2023 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2023)
Associated products mentioned in payments ›
Most payments (78%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Rahmani is a mixed practice specialist, with above-average Medicare volume (top 12% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Rahmani experienced with tocilizumab injection (actemra)?
Does Dr. Rahmani receive payments from pharmaceutical companies?
How do Dr. Rahmani's costs compare to other rheumatologys in Round Rock?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology